Medicare Enrolled

Dr. Pawan Gundavaram

Hematology & Oncology · Roselle, NJ
Low-engagement
776 E 3RD AVE, Roselle, NJ 07203
9082598817
In practice since 2007 (18 years)
NPI: 1174717300 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gundavaram from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gundavaram? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gundavaram

Dr. Pawan Gundavaram is a hematology & oncology specialist in Roselle, NJ, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Gundavaram received a total of $11,720 from 50 pharmaceutical and/or device companies across 418 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gundavaram is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice $11,720 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗
$11,720
Total received (2018-2023)
Avg $1,953/year across 6 years
Top 25% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
418
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,264 (53.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,568 (21.9%)
Other
Charitable contributions, space rental, and other categories
$1,733 (14.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,155 (9.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$167
2022
$1,281
2021
$2,841
2020
$6,001
2019
$1,118
2018
$312

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Novartis Pharmaceuticals Corporation
$3,146
AstraZeneca Pharmaceuticals LP
$1,686
Jazz Pharmaceuticals Inc.
$1,100
Incyte Corporation
$596
Daiichi Sankyo Inc.
$554
E.R. Squibb & Sons, L.L.C.
$519
Merck Sharp & Dohme Corporation
$460
Athenex Pharmaceutical Division, LLC
$350
Amgen Inc.
$323
Pharmacyclics LLC, An AbbVie Company
$253
Seagen Inc.
$231
Astellas Pharma US Inc
$231
NOVARTIS PHARMACEUTICALS CORPORATION
$167
PFIZER INC.
$162
Celgene Corporation
$155
Bayer HealthCare Pharmaceuticals Inc.
$140
Alexion Pharmaceuticals, Inc.
$129
Kite Pharma, Inc.
$127
Lilly USA, LLC
$117
Eisai Inc.
$111
GlaxoSmithKline, LLC.
$106
Takeda Pharmaceuticals U.S.A., Inc.
$105
Janssen Biotech, Inc.
$91
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Gilead Sciences, Inc.
$75
GENZYME CORPORATION
$67
Teva Pharmaceuticals USA, Inc.
$46
Exelixis Inc.
$40
Sirtex Medical Inc
$39
Mylan Institutional Inc.
$38
JAZZ PHARMACEUTICALS INC.
$38
Ipsen Biopharmaceuticals, Inc
$37
Octapharma USA, Inc.
$35
AVEO Pharmaceuticals, Inc.
$33
Karyopharm Therapeutics Inc.
$30
Epizyme, Inc.,
$28
Rigel Pharmaceuticals, Inc.
$28
iRhythm Technologies, Inc.
$28
TG THERAPEUTICS, INC.
$27
ARRAY BIOPHARMA INC
$27
Puma Biotechnology, Inc.
$25
Merck Sharp & Dohme LLC
$25
Secura Bio, Inc.
$17
Althera Pharmaceuticals LLC
$16
Fortovia Therapeutics, Inc.
$15
Genentech USA, Inc.
$15
AMAG Pharmaceuticals, Inc.
$14
TOLMAR Pharmaceuticals, Inc.
$13
Global Blood Therapeutics, Inc.
$13
AbbVie Inc.
$11
Top 3 companies account for 50.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · BAVENCIO · BENDEKA · BENLYSTA · BLENREP · BRAFTOVI · CABOMETYX · CERDELGA · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · ELIGARD · EMPLICITI · ENHERTU · ERLEADA · Enhertu · FASLODEX · FERAHEME · FOTIVDA · Fulphila · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · ONUREG · OPDIVO · OXBRYTA · Ogivri · PADCEV · PROMACTA · Pomalyst · REBLOZYL · Reblozyl · Roszet · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · Tavalisse · Trodelvy · Truxima · Turalio · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · WILATE · XALKORI · XPOVIO · XTANDI · Xofigo · Yescarta · ZEJULA · ZEPZELCA · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Roselle?
Compare hematology & oncology specialists in the Roselle area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
635
Per 100K population
110.9
County median income
$100,117
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
3.3 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gundavaram is a hematology & oncology specialist, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Gundavaram receive payments from pharmaceutical companies?
Yes. Dr. Gundavaram received a total of $11,720 from 50 companies across 418 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Gundavaram) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Roselle
Browse hematology & oncology specialists in Roselle ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Jazz Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Jazz Pharmaceuticals Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →